Support the development of a rapid and simple enhanced upstream process to provide more products faster!
The "XCell ATF Lab Devices" can scale up linearly from PD to manufacturing. The "XCell ATF 1 device" features a minimal capacity and includes accessories such as AseptiQuik connectors and permeable liquid pressure sensors. The "0.5-2L XCell ATF 1" reduces media costs and supports scale-up to 5000L. 【Features of XCell ATF Technology】 ■ Delivering faster and more - Improved throughput - Increased productivity - Enhanced cell capacity *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【Other Features of XCell ATF Technology】 ■ Execute business decisions with high ROI ・Bioreactor size can be reduced by up to 10 times ・Accelerated programs ・Reconsideration of facility expansion *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Repligen (hereinafter referred to as our company) is a life sciences company specialized in bioprocessing, providing over 35 years of expertise and innovation to our customers. We promote advancements in bioprocessing through products that address critical steps in the manufacturing of biological products, primarily monoclonal antibodies, and through the development and commercialization of flexible solutions to our customers' challenges. Our products are utilized in filtration, separation, purification, and concentration operations in pharmaceuticals, clinical analytical reagents, food, beverages, and industrial process liquids. Our manufacturing facilities are located in Waltham, Massachusetts, USA; Lund, Sweden; Waiblingen, Germany; Rancho Dominguez, California, USA; and Shrewsbury, Massachusetts, USA. Additionally, we sell our products globally through strategic partners in the United States, Europe, and Asia.